Indivior Pharmaceuticals (INDV) Stock Insights

INDV price $34.77 +0.05 +0.14%

Ticker
INDV
Price
$34.77
Change
+0.05 +0.14%
Market cap ?
$4.34B
P/E ?
12.17
Forward P/E ?
8.24
Dividend yield ?
0.00%
Beta ?
1.11
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stocklytics score
69
Value
55
Quality
72
Growth
80

Stocklytics score rationale: value 55, quality 72, growth 80.

Financials

2016201720182019202020212022202320242025
9688854631148105410959924667785000000647000000791000000901000000109300000011880000001239000000

Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United…

Fair value

INDV fair value $73.67. Price $34.77. Price is 53% below fair value.

Above fair value, and more expensive than usual. A larger premium than on 89% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 338.17M. Growth 7.51%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.42% (beta 1.1). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 124.77M. Net debt 156.00M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare INDV

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-29—1.06—329.35M
2026-08-031.150.87343.00M306.23M
2026-04-300.960.64317.00M272.84M
2026-02-260.820.65358.00M305.62M
2025-10-300.720.38314.00M306.22M
2025-07-310.510.26302.00M255.23M
2025-04-240.410.22266.00M242.30M
2025-02-200.320.32299.00M240.13M
2024-10-240.540.31307.00M260.43M
2024-07-250.440.40299.61M289.37M
2024-04-250.370.42282.74M299.75M
2024-02-220.430.28300.65M276.00M
2023-11-090.340.30261.20M270.50M
2023-07-270.390.22279.85M255.00M
2023-04-270.40—256.80M302.67M
2023-02-160.27—241.00M223.00M
2022-10-270.29—232.00M217.00M
2022-07-280.30—221.00M219.00M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Irregular.

Safety score 49/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividends were paid in 3 separate years. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2026-11-03$8.132026-10-302026-11-06Irregular
2016-06-16$0.472016-06-172016-07-29Semi-Annual
2015-09-17$0.162015-09-182015-10-23Irregular

Insider trades

DateInsiderActionSharesPriceValue
2028-06-02Barry Patrick AOther130.31K——
2028-05-08Ciaffoni JosephOther422.30K——
2028-03-07Preblick RyanOther70.46K——
2028-03-07Heidbreder ChristianOther82.29K——
2028-03-07Burris Jeffrey WOther71.74K——
2028-03-07Anderson Woodrow DOther29.48K——
2026-08-27Anderson Woodrow DBuy1.50K$35.6953.53K
2026-08-05Anderson Woodrow DBuy1.50K$36.2854.42K
2026-07-10Heidbreder ChristianSell18.59K$41.14764.63K
2026-06-22Ciaffoni JosephBuy1.27M——
2026-06-22Ciaffoni JosephSell612.55K$38.3223.47M
2026-06-22Ciaffoni JosephSell1.27M——
2026-06-11Heidbreder ChristianSell18.59K$38.06707.38K
2026-06-08Preblick RyanSell36.00K$37.701.36M
2026-05-13Thompson JulietBuy6.52K——
2026-05-13Humphreys KeithBuy6.52K——
2026-05-13Kingsley Stuart ABuy6.52K——
2026-05-13NINIVAGGI DANIEL ABuy6.52K——
2026-05-13Ryan BarbaraBuy6.52K——
2026-05-13Stejbach MarkBuy6.52K——
2026-05-13Wheadon David E.Buy10.43K——
2026-05-12Thompson JulietSell1.12K$38.2842.76K
2026-03-14Preblick RyanBuy6.30K——
2026-03-14Preblick RyanSell2.84K$31.1188.45K
2026-03-14Preblick RyanSell6.30K——
2026-03-13Ryan BarbaraBuy8$31.09249
2026-03-09Ryan BarbaraBuy31$32.561.01K
2026-03-06Kingsley Stuart ABuy940$31.8629.95K
2026-03-03Anderson Woodrow DBuy18.36K——
2026-03-03Anderson Woodrow DBuy5.95K——
2026-03-03Anderson Woodrow DSell2.68K$31.9885.77K
2026-03-03Anderson Woodrow DSell8.28K$31.98264.89K
2026-03-03Anderson Woodrow DSell23.98K——
2026-03-03Anderson Woodrow DSell5.95K——
2026-03-03Preblick RyanBuy86.95K——
2026-03-03Preblick RyanSell87.60K$31.982.80M
2026-03-03Preblick RyanSell113.51K——
2026-03-03Burris Jeffrey WBuy79.89K——
2026-03-03Burris Jeffrey WSell36.03K$31.981.15M
2026-03-03Burris Jeffrey WSell104.30K——
2026-03-03Heidbreder ChristianBuy101.54K——
2026-03-03Heidbreder ChristianSell45.80K$31.981.46M
2026-03-03Heidbreder ChristianSell132.56K——
2026-02-10Anderson Woodrow DBuy6.90K——
2026-02-10Preblick RyanBuy37.36K——
2026-02-10Burris Jeffrey WBuy26.90K——
2026-02-10Heidbreder ChristianBuy33.62K——
2026-02-10Barry Patrick ABuy31.38K——
2026-02-10Ciaffoni JosephBuy79.98K——
2026-02-09Anderson Woodrow DBuy23.98K——
2026-02-09Preblick RyanBuy113.51K——
2026-02-09Burris Jeffrey WBuy104.30K——
2026-02-09Heidbreder ChristianBuy132.56K——
2026-01-26Kingsley Stuart ABuy3.72K——
2026-01-26Wheadon David E.Buy5.96K——
2026-01-26Ryan BarbaraBuy3.72K——
2026-01-26NINIVAGGI DANIEL ABuy3.72K——
2026-01-26Stejbach MarkBuy3.72K——
2026-01-26Thompson JulietBuy3.72K——
2026-01-26Humphreys KeithBuy3.72K——
2026-01-05Ryan BarbaraBuy775$35.3927.43K
2026-01-05Humphreys KeithBuy775$35.3927.43K
2026-01-05NINIVAGGI DANIEL ABuy775$35.3927.43K
2026-01-05Stejbach MarkBuy775$35.3927.43K
2026-01-05Wheadon David E.Buy1.77K$35.3962.68K
2026-01-01Ryan BarbaraOther0——
2026-01-01NINIVAGGI DANIEL AOther0——
2026-01-01Kingsley Stuart AOther0——
2026-01-01Thompson JulietOther0——
2026-01-01Thompson JulietOther0——
2026-01-01Stejbach MarkOther0——
2026-01-01Ciaffoni JosephOther0——
2026-01-01Ciaffoni JosephOther1.27M——
2026-01-01Wheadon David E.Other0——
2026-01-01Preblick RyanOther0——
2026-01-01Humphreys KeithOther0——
2026-01-01Heidbreder ChristianOther0——
2026-01-01Burris Jeffrey WOther0——
2026-01-01Anderson Woodrow DOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 348, holders +51 vs prior quarter. Ownership 97.83%.

HolderSharesChangeChange %Value
BLACKROCK, INC.18.71M167.21K+0.90%767.65M
VANGUARD PORTFOLIO MANAGEMENT LLC7.57M-319.53K-4.05%310.69M
OAKTREE CAPITAL MANAGEMENT LP6.13M-856.89K-12.27%251.40M
VANGUARD CAPITAL MANAGEMENT LLC5.50M-91.09K-1.63%225.48M
STATE STREET CORP4.99M88.08K+1.80%204.82M
FULLER & THALER ASSET MANAGEMENT, INC.4.62M86.23K+1.90%189.39M
TWO SEAS CAPITAL LP3.48M-1.27M-26.69%142.76M
MORGAN STANLEY3.40M-110.11K-3.14%139.33M
FRANKLIN TEMPLETON INC3.32M3.20M+2871.83%136.07M
GEODE CAPITAL MANAGEMENT, LLC3.16M234.18K+8.00%129.68M
MADISON AVENUE PARTNERS, LP2.87M-1.44M-33.39%117.94M
MANGROVE PARTNERS IM, LLC2.68M-65.70K-2.40%109.83M
CITADEL ADVISORS LLC2.67M-906.22K-25.36%109.46M
DRIEHAUS CAPITAL MANAGEMENT LLC2.30M419.01K+22.29%94.33M
MILLENNIUM MANAGEMENT LLC2.10M-2.50M-54.33%86.12M
DIMENSIONAL FUND ADVISORS LP1.90M564.48K+42.37%77.82M
INVESCO LTD.1.84M281.22K+18.01%75.62M
DEERFIELD MANAGEMENT COMPANY, L.P.1.65M-1.45M-46.77%67.65M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.64M-681.18K-29.32%67.37M
ASSENAGON ASSET MANAGEMENT S.A.1.54M1.54MNew63.22M
FEDERATED HERMES, INC.1.47M251.03K+20.61%60.26M
JANE STREET GROUP, LLC1.36M1.36MNew55.67M
NEWTYN MANAGEMENT, LLC1.31M-694.21K-34.71%53.58M
POINT72 ASSET MANAGEMENT, L.P.1.25M1.16M+1217.25%51.31M
NORTHERN TRUST CORP1.24M80.37K+6.92%50.95M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Indivior Pharmaceuticals (INDV) Stock Insights

INDV$34.77+0.05 +0.14%

$4.34B

Market Cap

12.17

P/E

8.24

Forward P/E

69

Score

Price History